Prolactin Suppresses GnRH but Not TSH Secretion
- 1 January 2006
- journal article
- research article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 65 (1) , 31-38
- https://doi.org/10.1159/000090377
Abstract
Background/Aims: In animal models, prolactin increases tuberoinfundibular dopamine turnover, which has been demonstrated to suppress both hypothalamic GnRH and pituitary TSH secretion. To test the hypothesis that prolactin suppresses GnRH and TSH secretion in women, as preliminary evidence that a short-feedback dopamine loop also operates in the human, the effect of hyperprolactinemia on GnRH and TSH secretion was examined. Methods: Subjects (n = 6) underwent blood sampling every 10 min in the follicular phase of a control cycle and during a 12-hour recombinant human prolactin (r-hPRL) infusion preceded by 7 days of twice-daily subcutaneous r-hPRL injections. LH and TSH pulse patterns and menstrual cycle parameters were measured. Results: During the 7 days of r-hPRL administration, baseline prolactin increased from 16.0 ± 3.0 to 101.6 ± 11.6 µg/l, with a further increase to 253.7 ± 27.7 µg/l during the 12-hour infusion. LH pulse frequency decreased (8.7 ± 1.0 to 6.0 ± 1.0 pulses/12 h; p < 0.05) with r-hPRL administration, but there were no changes in LH pulse amplitude or mean LH levels. There were also no changes in TSH pulse frequency, mean or peak TSH. The decreased LH pulse frequency did not affect estradiol, inhibin A or B concentrations, or menstrual cycle length. Conclusion: These studies demonstrate that hyperprolactinemia suppresses pulsatile LH secretion but not TSH secretion and suggest that GnRH secretion is sensitive to hyperprolactinemia, but that TSH secretion is not. These data further suggest that the degree of GnRH disruption after 7 days of hyperprolactinemia is insufficient to disrupt menstrual cyclicity.Keywords
This publication has 57 references indexed in Scilit:
- A Replication-Limited Recombinant Mycobacterium bovis BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacious than BCGInfection and Immunity, 2008
- Free -Subunit Is Superior to Luteinizing Hormone as a Marker of Gonadotropin-Releasing Hormone Despite Desensitization at Fast Pulse FrequenciesJournal of Clinical Endocrinology & Metabolism, 1999
- Female Reproductive Aging Is Marked by Decreased Secretion of Dimeric InhibinJournal of Clinical Endocrinology & Metabolism, 1999
- Hyperprolactinemia suppresses the luteinizing hormone responses to N- methyl-D-aspartate, epinephrine, and neuropeptide-Y in male ratsEndocrinology, 1993
- Effects of acute hyperprolactinemia on LH pulsatile secretion in hypogonadal and early follicular phase womenLife Sciences, 1988
- Hyperprolactinemia Alters the Frequency and Amplitude of Pulsatile Luteinizing Hormone Secretion in the Ovariectomized RatNeuroendocrinology, 1986
- PROLACTIN AND TSH RESPONSES TO BOTH DOMPERIDONE AND TRH IN NORMAL AND HYPERPROLACTINAEMIC WOMEN AFTER DOPAMINE SYNTHESIS BLOCKADEClinical Endocrinology, 1985
- DOPAMINERGIC CONTROL OF GONADOTROPHIN SECRETION IN NORMAL WOMEN AND IN PATIENTS WITH PATHOLOGICAL HYPERPROLACTINAEMIAClinical Endocrinology, 1984
- RECIPROCAL PATTERN OF THE TSH AND PRL RESPONSES TO DOPAMINE RECEPTOR BLOCKADE IN WOMEN WITH PHYSIOLOGICAL OR PATHOLOGICAL HYPERPROLACTINAEMIAClinical Endocrinology, 1983
- ALTERED DOPAMINERGIC REGULATION OF THYROTROPHIN RELEASE IN PATIENTS WITH PROLACTINOMAS: COMPARISON WITH OTHER TESTS OF HYPOTHALAMIC-PITUITARY FUNCTIONClinical Endocrinology, 1981